Back to Search Start Over

Synergistic Anti-Myeloma Activity of a Proteasome Inhibitor Marizomib and IMiD® Immunomodulatory Drug Pomalidomide

Authors :
Das, Deepika Sharma
Ravillah, Durgadevi
Ray, Arghya
Song, Yan
Richardson, Paul G.
Trikha, Mohit
Chauhan, Dharminder
Anderson, Kenneth C.
Source :
Blood; December 2014, Vol. 124 Issue: 21 p2099-2099, 1p
Publication Year :
2014

Abstract

Richardson: Oncopeptides AB: Membership on an entity's Board of Directors or advisory committees; Celgene: Membership on an entity's Board of Directors or advisory committees; Millennium: Membership on an entity's Board of Directors or advisory committees. Trikha:Triphase Accelerator: Employment. Chauhan:Triphase Accelerator: Consultancy. Anderson:Celgene: Consultancy; Millenium: Consultancy; Onyx: Consultancy; Gilead: Consultancy; Sanofi Aventis: Consultancy; BMS: Consultancy; Oncopep/Acetylon: Equity Ownership.

Details

Language :
English
ISSN :
00064971 and 15280020
Volume :
124
Issue :
21
Database :
Supplemental Index
Journal :
Blood
Publication Type :
Periodical
Accession number :
ejs53016098
Full Text :
https://doi.org/10.1182/blood.V124.21.2099.2099